Lyon, F-69372
France
University of Claude Bernard Lyon 1 - CIRI
SARS-CoV-2, breakthrough infection, hybrid immunity, immune trajectory, IgG4 class-switching, ADCC function
Covid-19vaccinationantibodiesneutralizing antibodiesvirus-specific T cellsvaccine effectiveness
IgA, COVID-19, severity, lung, polyfunctionality
RSV, HMPV, chimeric virus, bivalent vaccine, live attenuated vaccine, vectored vaccine, reverse genetics, gene insertion, respiratory viruses, pneumovirus, bronchiolitis
HIV-1, Neutrophils, Inflammation